Sponsored Links

 

Displaying ticagrelor PowerPoint Presentations



PowerPoint Presentation PPT

Presentation Summary : Ticagrelor compared with clopidogrel in patients with acute coronary syndromes – the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI ...

Source : http://assets.cardiosource.com/Wallentin_PLATO.ppt

Comparing ticagrelor versus prasugrel for the treatment of ... PPT

Presentation Summary : Title: Comparing ticagrelor versus prasugrel for the treatment of patients with acute coronary syndromes: evidence from a 32,983-patient adjusted indirect comparison ...

Source : http://www.clinicaltrialresults.org/Slides/Prasugrel%20vs%20Ticagrelor.ppt

PowerPoint Presentation PPT

Presentation Summary : STEMI Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial Outcomes in patients with ...

Source : http://assets.cardiosource.com/Steg_PLATO.ppt

Slides - Clinical Trial Results PPT

Presentation Summary : Randomized Double-Blind Assessment of the ONSET and OFFSet of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients with Stable Coronary Artery Disease:

Source : http://www.clinicaltrialresults.org/Slides/ONSET-OFFSET.ppt

UPDATE ON ANTIPLATELET THERAPY IN THE TREATMENT AND ... PPT

Presentation Summary : ... Ticagrelor 180 mg loading dose, 90mg BID Clopidogrel 300-600 mg loading dose, 75 mg QD All patients received ASA 75-325 mg Wallentin, L et al NEJM 2009; ...

Source : http://www.pitt.edu/~super4/40011-41001/40131-40141.ppt

Aggregation on Aspirin, Aspirin + Clopidogrel, and Aspirin ... PPT

Presentation Summary : Aggregation on Aspirin, Aspirin + Clopidogrel, and Aspirin + Ticagrelor. 8 hrs post-180 mg ticagrelor load. Aggregation in 42% of pts on clopidogrel + aspirin:

Source : http://www.accelmed.org/prog/Red_Paris_Gurbel.pptx

Prasugrel in all ACS Patients! - metcardio.org PPT

Presentation Summary : Prasugrel vs ticagrelor in acute coronary syndromes. Giuseppe Biondi-Zoccai, MD. Sapienza University ofRome, Italy. giuseppe.biondizoccai@uniroma1.it

Source : http://www.metcardio.org/ppts/2013/Biondi-Zoccai_ICICEM_2013_Prasugrel_ticagrelor.pptx

Cangrelor - BCIS PPT

Presentation Summary : ... mediators TP a Coagulation GPVI Collagen ATP ATP P2X 1 ASPIRIN x TICLOPIDINE CLOPIDOGREL PRASUGREL ACTIVE METABOLITE x TICAGRELOR CANGRELOR GP IIb/IIIa ...

Source : http://www.bcis.org.uk/resources/documents/ACI2010/1035%20Storey/New%20antithrombotic%20agents%20v2.ppt

PowerPoint Presentation PPT

Presentation Summary : We suggest ticagrelor 90 mg twice daily plus low-dose aspirin over clopidogrel 75 mg daily plus low-dose aspirin (Grade 2B).

Source : http://www.chestnet.org/~/media/chesnetorg/Guidelines%20and%20Resources/Documents/Guidelines%20and%20Consensus%20Statements/20PrimSecPrevofCardiovasDis.ashx

Dual Antiplatelet Therapy - Hunter New England Health ... PPT

Presentation Summary : Dual antiplatelet therapy with aspirin and clopidogrel standard of care. ... Clopidogrel or ticagrelor awaiting decision regarding cath/PCI/CABG. Urgency…. Offset.

Source : http://www.gardinerlibrary.com/media/Cardio2012/Dual_antiplatelet_therapy.pptx

PowerPoint Presentation PPT

Presentation Summary : Ticagrelor and its active metabolite are approximately equipotent. Transitioning from clopidogrel to ticagrelor resulted in an absolute inhibition of platelet ...

Source : http://www.palmettohealth.org/documents/Baptist%20CME/Cardiovascular%20NDU%20Palmetto%20Baptist%201%2D2013%20CWW%20updated%201%2D2%2D13.ppt

Perioperative Management of New Antithrombotic Agents PPT

Presentation Summary : * * Background—Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist.

Source : http://imedia2012.hightech-cardio.net/download/IMEDIA/HTC2012/samama.ppt

Slide 1 PPT

Presentation Summary : ... ticagrelor reduces cardiovascular endpoints with this benefit offset by non-procedure-related bleeding. Ticagrelor Place in Therapy Clopidogrel issue ...

Source : http://www.acha.org/AnnualMeeting/webhandouts_2012/WE2-130%20D_Sturpe.ppt

Acute Coronary Syndromes PPT

Presentation Summary : Acute Coronary Syndromes January 9, 2011 Chris Chiles M.D. FACC

Source : http://2012fundamentals.files.wordpress.com/2011/12/acute-coronary-syndromes-2009-2.ppt

PowerPoint Presentation PPT

Presentation Summary : Antiplatelet Therapy in UA/NSTEMI Antiplatelet Therapy to Support Primary PCI for STEMI Case 1 Case 2 ... (Age 75 years) Ticagrelor Pharmacodynamics ...

Source : http://img.medscape.com/images/806/372/806372_slide.ppt

The Evolution of Antiplatelet Therapy in ACS and PCI PPT

Presentation Summary : P2Y 12 inhibitor therapy (clopidogrel, prasugrel, or ticagrelor for at least 12 months in patients receiving a stent (BMS or DES) during PCI for ACS . I. B.

Source : http://www.inosteo.org/UserFiles/File/PowerPoint/32nd%20Annual%20Winter%20Update/Saturday/Examining%20Contemporary%20Antilplatelet%20Strategies%20.Villanueva.pptx

Canadian Cardiovascular Society - Thrombosis Canada ... PPT

Presentation Summary : Ticagrelor (PLATO) and Non-CABG-related TIMI major bleedingAccording to creatinine clearance over or under 60 ml/min. James S et al. Circulation 2010; 122: 1056-67

Source : http://www.tigc.org/getattachment/4b977ea8-0a29-44c2-9ba2-a7bed44f31f5/CKD-CCS-APT-TIG_June-16.aspx

Antiplatelet Therapy for Secondary Prevention in the First ... PPT

Presentation Summary : Antiplatelet Therapy for Secondary Prevention in the First Year Following an Acute Coronary Syndrome. ... Ticagrelor. 180 mg loading dose, then. 90 mg bid maintenance;

Source : http://www.tigc.org/getattachment/8376d824-db46-49c2-a38e-72d34ffc490c/ACS.aspx

Acute coronary syndrome - CardioSource - Home PPT

Presentation Summary : Results Conclusions Wallentin L, et al. N Engl J Med 2009;Aug 30:[Epub] (p < 0.001) Ticagrelor (n = 9,333) Clopidogrel (n = 9,291) Primary ...

Source : http://www.cardiosource.com/img/ESC09_Compilation.ppt

Sponsored Links
If you find powerpoint presentation a copyright It is important to understand and respect the copyright rules of the author.
Please do not download if you find presentation copyright.
If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com